
India on Friday stepped closer to getting its first Covid-19 vaccine with the expert committee of the national drug regulator recommending emergency use approval to the Oxford University/AstraZeneca/Serum Institute of India candidate Covishield.
Covishield gets expert panel nod, ball now in DCGI court
Expert panel recommends SII’s Covishield for emergency use: Sources
As expert panel recommends Covishield, health activists flag efficacy data